These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 35323982)

  • 1. Characteristics of natural immunity to SARS-CoV-2 over time in wait-listed dialysis patients and recent kidney transplant recipients.
    Lubetzky M; Zhao Z; Sukhu A; Sharma V; Sultan S; Kapur Z; Albakry S; Craig-Schapiro R; Lee JR; Salinas T; Aull M; Kapur S; Cushing M; Dadhania DM
    Nephrol Dial Transplant; 2022 Jul; 37(8):1585-1587. PubMed ID: 35323982
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response.
    Alberici F; Affatato S; Moratto D; Mescia F; Delbarba E; Guerini A; Tedesco M; Burbelo PD; Zani R; Castagna I; Gallico A; Tonoli M; Venturini M; Roccaro AM; Giacomelli M; Cohen JI; Giustini V; Dobbs K; Su HC; Fiorini C; Quaresima V; Viola FB; Vizzardi V; Gaggiotti M; Bossini N; Gaggia P; Badolato R; Notarangelo LD; Chiarini M; Scolari F
    J Nephrol; 2022 Apr; 35(3):745-759. PubMed ID: 35067905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients.
    Kemlin D; Lemy A; Pannus P; Desombere I; Gemander N; Goossens ME; Marchant A; Le Moine A
    Am J Transplant; 2022 Mar; 22(3):994-995. PubMed ID: 34554629
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes of COVID-19 infection in patients on dialysis and kidney transplant recipients: A single-centre audit.
    Fong JMN; Ramirez MEG; Kee YST; Gan SWS; Foo MWY; Kaushik M; Tan CS
    Ann Acad Med Singap; 2023 Dec; 52(12):700-703. PubMed ID: 38920163
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of SARS-CoV-2 mRNA vaccine in dialysis and kidney transplant patients: A systematic review.
    Akyol M; Çevik E; Ucku D; Tanrıöver C; Afşar B; Kanbay A; Covic A; Ortiz A; Basile C; Kanbay M
    Tuberk Toraks; 2021 Dec; 69(4):547-560. PubMed ID: 34957748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the need to better protect hemodialysis patients: a comment on "IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)".
    Torreggiani M; Fessi H; Piccoli GB
    Kidney Int; 2021 Mar; 99(3):770. PubMed ID: 33444544
    [No Abstract]   [Full Text] [Related]  

  • 7. A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse.
    Westhoff TH; Seibert FS; Anft M; Blazquez-Navarro A; Skrzypczyk S; Zgoura P; Meister TL; Pfaender S; Stumpf J; Hugo C; Viebahn R; Roch T; Stervbo U; Babel N
    Kidney Int; 2021 Nov; 100(5):1135-1136. PubMed ID: 34509489
    [No Abstract]   [Full Text] [Related]  

  • 8. Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.
    Rincon-Arevalo H; Choi M; Stefanski AL; Halleck F; Weber U; Szelinski F; Jahrsdörfer B; Schrezenmeier H; Ludwig C; Sattler A; Kotsch K; Potekhin A; Chen Y; Burmester GR; Eckardt KU; Guerra GM; Durek P; Heinrich F; Ferreira-Gomes M; Radbruch A; Budde K; Lino AC; Mashreghi MF; Schrezenmeier E; Dörner T
    Sci Immunol; 2021 Jun; 6(60):. PubMed ID: 34131023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1498-1500. PubMed ID: 33887315
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney transplant rejection rate in screened patients for anti-SARS-CoV-2 antibodies, during COVID-19 pandemic in Northern Italy.
    Asti AL; Lilleri D; Gregorini M; Zelini P; Pattonieri EF; Sepe V; Libetta C; Islami T; Baldanti F; Rampino T
    New Microbiol; 2021 Jul; 44(3):184-186. PubMed ID: 34783351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 infection in solid organ transplant recipients: A single-center experience with patients immediately after transplantation.
    Kolonko A; Dudzicz S; Wiecek A; Król R
    Transpl Infect Dis; 2021 Feb; 23(1):e13381. PubMed ID: 32578289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Kidney Transplant During the SARS-CoV-2 Pandemic at 1 Center in Poland.
    Wojas W; Kotowski MJ; Marczak I; Ostrowski P; Ostrowski M; Sieńko J
    Transplant Proc; 2022 May; 54(4):888-889. PubMed ID: 35637012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and longevity of antibodies against SARS-CoV-2 in kidney transplant recipients after symptomatic COVID-19.
    Bajpai D; Shah D; Bose S; Deb S; Gandhi C; Modi T; Rao N; Kumar K; Saxena N; Katyal A; Patil A; Thakare S; Pajai AE; Nataraj G; Jamale TE
    Transpl Infect Dis; 2021 Aug; 23(4):e13646. PubMed ID: 34028939
    [No Abstract]   [Full Text] [Related]  

  • 15. Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine.
    Piotrowska M; Zieliński M; Tylicki L; Biedunkiewicz B; Kubanek A; Ślizień Z; Polewska K; Tylicki P; Muchlado M; Sakowska J; Renke M; Sudoł A; Dąbrowska M; Lichodziejewska-Niemierko M; Smiatacz T; Dębska-Ślizień A; Trzonkowski P
    Front Immunol; 2022; 13():832924. PubMed ID: 35935974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
    Bouwmans P; Messchendorp AL; Sanders JS; Hilbrands L; Reinders MEJ; Vart P; Bemelman FJ; Abrahams AC; van den Dorpel MA; Ten Dam MA; de Vries APJ; Rispens T; Steenhuis M; Gansevoort RT; Hemmelder MH;
    BMC Nephrol; 2022 Feb; 23(1):55. PubMed ID: 35123437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing Coronavirus Disease 2019 in Kidney Transplant Recipients: Where Should We Begin?
    Riella LV; Azzi JR; Cravedi P
    Nephron; 2021; 145(3):280-284. PubMed ID: 33789316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
    Haller MC; Kaiser RA; Langthaler S; Brandstetter C; Apfalter P; Kerschner H; Cejka D
    Transpl Int; 2021; 35():10026. PubMed ID: 35185359
    [No Abstract]   [Full Text] [Related]  

  • 19. [COVID-19 vaccination in dialysis and kidney transplant patients].
    Sakhi H; Chavarot N; Attias P; El Karoui K; Anglicheau D
    Nephrol Ther; 2021 Aug; 17(4):208-213. PubMed ID: 34305020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?
    Juric I; Katalinic L; Furic-Cunko V; Basic-Jukic N
    Int Urol Nephrol; 2022 Jul; 54(7):1775-1776. PubMed ID: 34813025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.